Advancing Vascular Access: Rethinking Vein Visualisation for Modern Care

Few procedures are performed as frequently across healthcare systems as peripheral IV cannulation and blood collection. Despite its routine nature, difficult vein access continues to disrupt clinical flow, extend procedure times and increase patient distress. Emergency departments and paediatric units confront the same constraint: clinicians are expected to achieve success within one or two attempts, often under time pressure and with limited staff. When attempts fail, escalation to a second practitioner or consultant delays treatment and compounds anxiety for patients and families.

Capital-based vein detection systems were introduced to address this challenge, yet their deployment remains uneven. High acquisition costs limit the number of units available per facility, leaving devices stored centrally rather than positioned at the point of care. Shared equipment also introduces cleaning and transport requirements between rooms, which can slow throughput and raise infection control concerns. In ambulances, home infusion environments and resource-limited hospitals, such systems are often absent altogether. The gap between need and accessibility remains evident.

Decision-makers evaluating vein visualisation technologies should look beyond image projection alone. Practical value emerges when visualisation supports rapid site identification, enables a single clinician to complete the procedure and integrates into standard IV preparation without additional handling steps. The ability to assess vein depth and quality across varying skin tones is critical, particularly in diverse patient populations. Workflow integration matters as much as optical performance; devices that require a second operator or occupy a clinician’s hand may reduce their intended efficiency gains.

Infection prevention also deserves careful weighing. Peripheral IV placement is closely linked to downstream risks, including bloodstream infections that carry substantial treatment costs and patient harm. Any technology that increases contact with the insertion site or requires repeated surface disinfection adds complexity to compliance. A solution that arrives pre-sterilised and is discarded after use may align more closely with contemporary infection control standards, particularly in intensive care or high-turnover environments.

Economic structure is equally relevant. Administrators must weigh whether vein visualisation should remain a limited capital asset or become an affordable consumable embedded in every IV tray. When technology is inexpensive enough to be stocked in multiples, it becomes available during peak demand, emergency response or community-based care. Broader distribution supports equity across developed and developing settings, where access to capital equipment may be constrained.

EziVein addresses these considerations through a single-use, wearable transillumination device designed to sit directly on the patient’s skin. Instead of projecting an image from a handheld unit, it uses polychromatic light to illuminate veins through tissue, enabling clinicians to scan the site, identify an appropriate vessel and secure the device in place with a medical-grade adhesive before proceeding hands-free.

Testing has focused on performance across different skin tones and vein depths, aiming for broad applicability in routine and difficult cases. Its disposable format, pre-sterilised packaging and low-cost positioning allow it to be stocked in quantity across wards, ambulances and home infusion kits. For health systems evaluating practical, infection-conscious and scalable vein visualisation, EziVein represents a compelling and economically accessible choice grounded in workflow realities.